# Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Oral Dose

> **NCT04037618** · PHASE1 · COMPLETED · sponsor: **Enyo Pharma** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]-EYP001a

## Key facts

- **NCT ID:** NCT04037618
- **Lead sponsor:** Enyo Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-24
- **Primary completion:** 2019-07-27
- **Final completion:** 2019-08-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04037618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04037618, "Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Oral Dose". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04037618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*